CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Oculus Go Virtual Reality Headsetdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05267704
NCT05267704N/ACompleted
CompareCT.gov

Evaluating the Feasibility of Virtual Reality for Procedural Sedation in Pediatric Renal Biopsy Patients

University of California, San Francisco·interventional·Posted Mar 4, 2022·Updated Mar 12, 2026

In Brief

A clinical study evaluating Oculus Go Virtual Reality Headset for Pain, Procedural and 2 related conditions. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the use of virtual reality (VR) as an adjunct or alternative to pharmacologic sedation in pediatric patients undergoing renal biopsy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Procedural, Procedural Anxiety, Sedation Complication
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 4, 2022
Enrollment StartOct 11, 2022
Primary CompletionSep 8, 2024
Study CompletionSep 10, 2024
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 4.3 years ago

Interventions

Oculus Go Virtual Reality Headsetdevice

VR headset displaying preselected game during renal biopsy